LuxSci Welcomes Enterprise Software Executive Mark Leonard as New CEO

April 22nd, 2024

LuxSci is pleased to announce the appointment of Mark Leonard as CEO to fuel the company’s next phase of growth. Founder Erik Kangas continues as CTO to focus on product innovation and expansion.

Mark brings more than two decades of enterprise software experience to LuxSci, selling to both technical buyers and business users. He’s led sales, customer success and marketing teams at high-growth start-ups and scale-ups with a proven track record of success, including AI solution providers Cogito and Interactions, and insurance software provider Enservio. Mark’s unique executive leadership experience includes roles as Chief Revenue Officer, Executive Vice President of Customer Success and Chief Marketing Officer, bringing hands-on, real-world expertise in the full range of go-to-market activities to LuxSci.

“LuxSci has built an enterprise-class product and has established a leadership position in the market through sheer determination and an unmatched commitment to its customers’ success,” said Leonard. “I’m honored to join the team as we embark on LuxSci’s next phase of growth, and I want to especially thank founders Erik Kangas and Jeanne Fama, as well as Daan Visscher and the team over at Main Capital Partners, for this incredible opportunity.”

Mark Leonard LuxSci CEO

“It’s an exciting time! The addition of Mark to the LuxSci team marks an important milestone in the LuxSci journey, supporting our aspirations to be the leader in secure healthcare communications,” said Kangas. “We’re now positioned better than ever to understand our customers and the needs of the market to deliver solutions that make a real difference in today’s healthcare experience – from patients to providers, payers and suppliers.”

LuxSci in November received a majority investment from Main Capital Partners, one of Europe’s largest private equity firms. Main recently secured €2.44B in commitments for its latest fund, bringing its total assets under management to approximately €6B. With the financial strength and backing of Main, LuxSci has direct access to the firm’s market intelligence and performance excellence teams for data & research, best practices on go-to-market strategies, technology, financing and M&A – strongly positioning the company for continued innovation and future growth.

Today, LuxSci is used by nearly 2,000 customers for HIPAA-compliant email and marketing solutions across the healthcare industry, including Athena Health, 1800 Contacts, Delta Dental, Beth Israel Lahey Health, Hinge Health, and Rotech Healthcare.